3NC
CBST

300 North Capital’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

300 North Capital’s Portfolio CBST Stock Details CBST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-33,945
Closed -$2.25M – 128
2014
Q3 		$2.25M Sell
33,945
-846
-2% -$55.6K 0.6% 69
2014
Q2 		$2.43M Buy
34,791
+1,657
+5% +$113K 0.6% 68
2014
Q1 		$2.42M Buy
33,134
+1,978
+6% +$147K 0.63% 66
2013
Q4 		$2.15M Sell
31,156
-1,220
-4% -$79K 0.59% 72
2013
Q3 		$2.06M Buy
32,376
+16,006
+98% +$967K 0.48% 85
2013
Q2 		$790K Buy
+16,370
New +$805K 0.31% 87

Other funds holding CBST

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

300 North Capital's CBST Position: Q4 2014 in Review

300 North Capital sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q4 2014, closing a stake of 33,945 shares — an estimated $2.25M sold.

300 North Capital first reported a position in CBST in Q2 2013 and held it in 6 quarters. The position peaked at $2.43M in Q2 2014. 307 funds tracked by Wall St. Rank hold CBST as of Q4 2014.

  • 300 North Capital reported no remaining CUBIST PHARMACEUTICALS INC position as of Q4 2014 after selling out during the quarter.
  • 300 North Capital sold 33,945 CUBIST PHARMACEUTICALS INC shares in Q4 2014, an estimated $2.25M.
  • 300 North Capital first reported a position in CUBIST PHARMACEUTICALS INC in Q2 2013 and held it in 6 quarters.
  • 300 North Capital's CUBIST PHARMACEUTICALS INC position peaked at $2.43M in Q2 2014.
  • 307 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q4 2014.

Based on 300 North Capital's 13F filing for Q4 2014, filed 11 Feb 2015.